Xibrom - ISTA Pharmaceuticals, Inc. - New Indication Approved

Xibrom is now also approved for the reduction of ocular pain in patients who have undergone cataract surgery.

Posted: January 2006

Related Articles:

Xibrom (bromfenac) FDA Approval History

View comments

Hide
(web3)